Concepedia

Kunwar Shailubhai

KS

Statistics

Publications

32

Citations

1.4K

H-Index

22

Active since

1983

Affiliations

Synergy Pharmaceuticals (United States)(Current)

University of Maryland, College Park

Baruch S. Blumberg Institute

Maharaja Sayajirao University of Baroda

Brigham and Women's Hospital

Kunwar Shailubhai is an author at Synergy Pharmaceuticals (United States) specializing in pharmacology, life sciences, and medicine.

Publications per year

1983–2022

32

Publications

32

Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.

Kunwar Shailubhai, Haitao Yu, K. Karunanandaa et al. · PubMed · 2000 · 208 citations

, , +17

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation

Philip B. Miner, William Koltun, Gregory Wiener et al. · The American Journal of Gastroenterology · 2017 · 141 citations

, , +17

Plecanatide, an Oral Guanylate Cyclase C Agonist Acting Locally in the Gastrointestinal Tract, Is Safe and Well-Tolerated in Single Doses

Kunwar Shailubhai, Stephen Comiskey, John A. Foss et al. · Digestive Diseases and Sciences · 2013 · 98 citations

, , +4

Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod

Sweeta R. Choudhari, Muhammad Ajmal Khan, Genesis Harris et al. · Molecular Cancer Therapeutics · 2007 · 90 citations

, , +17

Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation

Michael DeMicco, Laura Barrow, Bernadette Hickey et al. · Therapeutic Advances in Gastroenterology · 2017 · 75 citations · Full text

, , +17

1–5 of 32